183 related articles for article (PubMed ID: 32037147)
21. Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon
Möckel M; De La Cruz NC; Rübsam M; Wirtz L; Tantcheva-Poor I; Malter W; Zinser M; Bieber T; Knebel-Mörsdorf D
J Virol; 2022 Sep; 96(17):e0086422. PubMed ID: 35969080
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP; Nguyen GH; Jin HZ
Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
[TBL] [Abstract][Full Text] [Related]
23. The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment.
Leonard A; Guttman-Yassky E
Clin Rev Allergy Immunol; 2019 Feb; 56(1):1-8. PubMed ID: 29754191
[TBL] [Abstract][Full Text] [Related]
24. IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases.
Mitamura Y; Nunomura S; Furue M; Izuhara K
Allergol Int; 2020 Jul; 69(3):405-411. PubMed ID: 31980374
[TBL] [Abstract][Full Text] [Related]
25. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transduction.
Andrews AL; Nordgren IK; Kirby I; Holloway JW; Holgate ST; Davies DE; Tavassoli A
Biochem Soc Trans; 2009 Aug; 37(Pt 4):873-6. PubMed ID: 19614610
[TBL] [Abstract][Full Text] [Related]
27. Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2.
Popovic B; Breed J; Rees DG; Gardener MJ; Vinall LM; Kemp B; Spooner J; Keen J; Minter R; Uddin F; Colice G; Wilkinson T; Vaughan T; May RD
J Mol Biol; 2017 Jan; 429(2):208-219. PubMed ID: 27956146
[TBL] [Abstract][Full Text] [Related]
28. New Cytokines in the Pathogenesis of Atopic Dermatitis-New Therapeutic Targets.
Klonowska J; Gleń J; Nowicki RJ; Trzeciak M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304837
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts.
Penke LR; Ouchi H; Speth JM; Lugogo N; Huang YJ; Huang SK; Peters-Golden M
Sci Rep; 2020 Jan; 10(1):1083. PubMed ID: 31974428
[TBL] [Abstract][Full Text] [Related]
30. New mechanism underlying IL-31-induced atopic dermatitis.
Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
[TBL] [Abstract][Full Text] [Related]
31. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
[TBL] [Abstract][Full Text] [Related]
32. The IL-13-OVOL1-FLG axis in atopic dermatitis.
Furue K; Ito T; Tsuji G; Ulzii D; Vu YH; Kido-Nakahara M; Nakahara T; Furue M
Immunology; 2019 Dec; 158(4):281-286. PubMed ID: 31509236
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
Werfel T; Allam JP; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon HU; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
J Allergy Clin Immunol; 2016 Aug; 138(2):336-49. PubMed ID: 27497276
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
[TBL] [Abstract][Full Text] [Related]
35. Drug evaluation review: dupilumab in atopic dermatitis.
Hamilton JD; Ungar B; Guttman-Yassky E
Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
[TBL] [Abstract][Full Text] [Related]
36. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
Melnik BC
Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
38. Paeonol inhibits the development of 1‑chloro‑2,4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice.
Meng Y; Liu Z; Zhai C; Di T; Zhang L; Zhang L; Xie X; Lin Y; Wang N; Zhao J; Wang Y; Li P
Mol Med Rep; 2019 Apr; 19(4):3217-3229. PubMed ID: 30816506
[TBL] [Abstract][Full Text] [Related]
39. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
40. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
